Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 3K views

    Ketorolac Drug Study

    Uploaded by

    Rose
    Ketorolac is a nonsteroidal anti-inflammatory drug used for short term management of pain. It works by inhibiting prostaglandin synthesis peripherally to produce analgesia and has antipyretic and anti-inflammatory properties. Ketorolac is administered intravenously in 30mg/mL doses every 6 hours for up to 5 days total. Common adverse effects include drowsiness, dizziness, headache, asthma, dyspnea, edema, pallor, vasodilation, abnormal taste, diarrhea, dry mouth, nausea, oliguria, and renal toxicity. Nursing responsibilities include monitoring blood pressure after administration and assessing for risk factors, pain levels, and potential adverse effects.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Ketorolac Drug Study

    Uploaded by

    Rose
    3K views1 page
    Ketorolac is a nonsteroidal anti-inflammatory drug used for short term management of pain. It works by inhibiting prostaglandin synthesis peripherally to produce analgesia and has antipyretic and anti-inflammatory properties. Ketorolac is administered intravenously in 30mg/mL doses every 6 hours for up to 5 days total. Common adverse effects include drowsiness, dizziness, headache, asthma, dyspnea, edema, pallor, vasodilation, abnormal taste, diarrhea, dry mouth, nausea, oliguria, and renal toxicity. Nursing responsibilities include monitoring blood pressure after administration and assessing for risk factors, pain levels, and potential adverse effects.

    Original Title

    Ketorolac Drug Study.docx

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Ketorolac is a nonsteroidal anti-inflammatory drug used for short term management of pain. It works by inhibiting prostaglandin synthesis peripherally to produce analgesia and has antipyretic and anti-inflammatory properties. Ketorolac is administered intravenously in 30mg/mL doses every 6 hours for up to 5 days total. Common adverse effects include drowsiness, dizziness, headache, asthma, dyspnea, edema, pallor, vasodilation, abnormal taste, diarrhea, dry mouth, nausea, oliguria, and renal toxicity. Nursing responsibilities include monitoring blood pressure after administration and assessing for risk factors, pain levels, and potential adverse effects.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    3K views1 page

    Ketorolac Drug Study

    Uploaded by

    Rose
    Ketorolac is a nonsteroidal anti-inflammatory drug used for short term management of pain. It works by inhibiting prostaglandin synthesis peripherally to produce analgesia and has antipyretic and anti-inflammatory properties. Ketorolac is administered intravenously in 30mg/mL doses every 6 hours for up to 5 days total. Common adverse effects include drowsiness, dizziness, headache, asthma, dyspnea, edema, pallor, vasodilation, abnormal taste, diarrhea, dry mouth, nausea, oliguria, and renal toxicity. Nursing responsibilities include monitoring blood pressure after administration and assessing for risk factors, pain levels, and potential adverse effects.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    You are on page 1of 1

    DRUG STUDY

    DRUG NAME MECHANISM ADMINIS- INDICA- CONTRA- ADVERSE  NURSING


    OF ACTION TRATION TION INDICATION EFFECTS RESPONSIBILITIES

    GENERIC NAME: - Inhibits Route: Short term - Hypersensitivity  - CNS: - Monitor BP upon
    Ketorolac prostaglandin I.V managem - Cross-sensitivity 1) drowsiness administration. < 90/80never
    synthesis, ent of pain with other NSAIDs 3) dizziness administer. Refer to doctor.
    BRAND NAME: producing Dose: (not to may exist ¨Pre- or 4) euphoria - Patients who have asthma,
    Toradol peripherally Q 6h exceed 5 perioperative use 5) headache aspirin-induced allergy, and
    mediated days total - RESP: nasal polyps are at increased
    CLASSIFICATION: analgesia Dosage: for all - Known alcohol 1) asthma risk for developing
    Nonsteroidal anti- 30mg/mL routes intolerance 2) dyspnea hypersensitivity reactions.
    inflammatory -Also has combined) Use cautiously in: - CV: - Assess for rhinitis, asthma,
    agents, nonopioid antipyretic and 1) edema and urticaria.
    analgesics anti-inflammatory 1) History of 2) pallor  - Assess pain (note type,
    properties. GI bleeding 3) vasodilation location, and intensity) prior to
    - GI: and 1-2 hr. following
    -Therapeutic 2) Renal 1) abnormal taste administration.
    effect: Decreased impairment 2) diarrhea - Ketorolac therapy should
    pain (dosage reduction 3) dry mouth always be given initially by the
    may be required) 4) nausea IM or IV route. Oral therapy
    should be used only as a
    3)Cardiovascular d - GU: continuation of parenteral
    isease 1) oliguria therapy.
    2) renal toxicity

    You might also like